Today's 3 Worst Stocks

Though Cyprus's worries earlier this week shook the market up, Cypriot banks reopened today, and instilled further confidence in the global financial system -- just enough to send the S&P 500 Index (SNPINDEX: ^GSPC  )  up to gains of 6.3 points, or 0.4%, ending at an all-time closing record of 1,569. Although it was an historic day for the iconic index, three of its members, in particular, couldn't do much more than hold it back.

Apple (NASDAQ: AAPL  ) slipped 2.1% on news that Chinese authorities will be cracking down on the company, scrutinizing issues such as the company's warranty policy in one of the world's largest and fastest-growing economies. Customer service policies in China are also under the microscope; it's important for the revered global brand to maintain its image in the world's second-largest economy. Apple and China Mobile are reportedly in talks to put the iPhone on the world's largest wireless carrier, which boasts hundreds of millions of subscribers. 

Alexion Pharmaceuticals (NASDAQ: ALXN  ) , which manaufactures Soliris, a drug used to treat blood disorders, was hit hard today by a warning issued by the Food and Drug Administration, or FDA, regarding an internal investigation into a bacterial issue at one of Alexion's facilities. Though the company claims the issues have been fixed, the FDA can prevent Alexion from selling products made in that facility if the agency isn't satisfied with their quality. The stock slipped 1.9% on the disheartening news. 

Lastly, Genworth Financial (NYSE: GNW  ) , a financial services company focusing mostly on life insurance, also lost 1.9% on Thursday. The business said yesterday that it would sell off its wealth management business for $412.5 million, taking total losses of close to $40 million on the transaction. Though Genworth stock's best days were years ago, shares have performed remarkably well in recent times, nearly doubling in price over the past six months.

There's no doubt that Apple is at the center of technology's largest revolution ever, and that longtime shareholders have been handsomely rewarded with over 1,000% gains. However, there's a debate raging as to whether Apple remains a buy. The Motley Fool's senior technology analyst and managing bureau chief, Eric Bleeker, is prepared to fill you in on both reasons to buy and reasons to sell Apple, and what opportunities are left for the company (and your portfolio) going forward. To get instant access to his latest thinking on Apple, simply click here now.


Read/Post Comments (0) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2337790, ~/Articles/ArticleHandler.aspx, 12/28/2014 8:02:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement